Latest Headlines
Bayer HealthCare Enhances U.S. Research Strategy with New Innovation Center. more
Bayer HealthCare Pharmaceuticals
A global biotechnology leader on the West Coast of the U.S.
Bayer HealthCare Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of innovative biotechnology and specialty pharmaceutical products that improve human health. Our growing presence on the West Coast of the United States includes campuses at Berkeley, Emeryville and Richmond, California and Seattle, Washington.We will open our U.S. Innovation Center at San Francisco's Mission Bay in the fourth quarter of 2010.
Bayer has more than 20 years of experience bringing complex protein-based therapies to market. The Bay Area is a global center for Bayer's biotechnology initiatives, and global functions of Bayer's pharmaceutical business. Bayer is the second largest biotechnology employer in the Bay Area; Berkeley is the headquarters of Bayer's global biotech manufacturing organization. The company's US research team is based in Richmond while development teams are based at Berkeley. The company's three primary supply centers for protein therapies are Berkeley (Kogenate®), Emeryville (Betaseron®) and Seattle (Leukine®).
In keeping with our mission of Science for a Better Life, we are poised to deliver the next generation of biotherapeutics that address unmet medical needs and improve human health.
* BETASERON® (Interferon beta-1b) Prescribing Information.
* Kogenate® FS Antihemophilic Factor (Recombinant) Prescribing Information.
* LEUKINE® (sargramostim) Prescribing Information.
